Sign in

NCT06909318Not yet recruiting

Animated Video and Booklet Education for Improving Asthma Control and Medication Compliance in Children

The Effect of Animated Video and Booklet Education on Asthma Control and Medication Compliance in Children With Asthma: A Randomized Controlled Study

Source: ClinicalTrials.gov · Last updated 8 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Asthma is a chronic inflammatory disease that causes wheezing, coughing, and shortness of breath, and it is a significant cause of morbidity and mortality in the pediatric population. The World Health Organization (WHO) estimated that 262 million people were affected by asthma in 2019, with 461,000 asthma-related deaths annually. In Turkey, the prevalence of asthma in children aged 6-12 ranges from 2% to 16%. Inadequate asthma control in children is often associated with poor medication adherence, lack of knowledge, misbeliefs, and ineffective communication with healthcare professionals. Education is therefore a crucial element of successful asthma management. Recently, the use of digital tools such as animated videos has become increasingly popular in pediatric education due to their engaging and interactive nature. Studies have shown that visual and interactive materials can improve knowledge, satisfaction, and adherence in children with chronic illnesses. This randomized controlled study aims to evaluate the effect of an educational intervention using an animated video and booklet on asthma control and medication compliance in children aged 7-11 diagnosed with asthma. It is expected that this child-friendly, visually enriched educational approach will enhance asthma management and support medication adherence in children.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
66 (estimated)
First submitted
27 Mar 2025
Start date
15 May 2025
Primary completion date
15 Sept 2025
Lead sponsor
Trakya University
Diseases
Asthma
NCT number
NCT06909318

What you commit to

  • Study type: Interventional
  • Planned participants: 66
  • From 15 May 2025 to the primary completion date, 15 Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior asthma education outside of routine clinical care

Age

  • Children younger than 7 or older than 11

Other

  • Severe persistent asthma according to GINA criteria
  • Communication difficulties
  • Children with cognitive or neurological impairments
  • Children who frequently require emergency care due to asthma exacerbations
  • Families without access to communication tools (e.g., no internet, smartphone, or unable to communicate)
  • Lack of consent from either the child or parent

Who the study is looking for

  • Children aged between 7 and 11 years
  • Diagnosed with asthma by a pediatric allergy specialist
  • Mild or moderate asthma severity according to GINA criteria
  • No communication difficulties
  • Have not received any asthma-related education outside of routine clinical care during the study period
  • No known mental or neurological disabilities
  • No serious chronic illness other than asthma (e.g., cardiac, neurological conditions)
  • At least one parent owns a smartphone or tablet
  • Child and parent volunteer to participate and provide informed consent

Age in the registry: 7 years to 11 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Trakya University Faculty of Health Sciences
Coordinator of this site? Confirm its status
EdirneTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.